Combined HR suggested that BCR-ABL1 isoforms did not significantly affect the OS of patients with Ph+ ALL (HR = 1.15, 95% CI 0.92–1.45) (Fig 2B). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.